/People

Eric d'Esparbes

Chief Financial Officer at Antheia, Inc.

Guadalajara, Mexico Metropolitan Area

Find your path to Eric

Sign up to see every warm intro you have to Eric

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Eric. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Eric d'Esparbes is Chief Financial Officer at Antheia, Inc. He previously served as interim CEO of the public companies Progenity in 2021 and Innoviva in 2018, and has held financial leadership roles across the pharmaceutical, biotech, diagnostics, and energy industries in Canada, Asia, and the United States. His experience includes managing IPO processes, capital raising, and reporting under SEC, US GAAP, and IFRS standards, as well as FDA and EMA regulatory environments.

Frequently asked questions

Who is Eric d'Esparbes?
Eric d'Esparbes is Chief Financial Officer at Antheia, Inc. He previously served as interim CEO of the public companies Progenity in 2021 and Innoviva in 2018, and has held financial leadership roles across the pharmaceutical, biotech, diagnostics, and energy industries in Canada, Asia, and the United States. His experience includes managing IPO processes, capital raising, and reporting under SEC, US GAAP, and IFRS standards, as well as FDA and EMA regulatory environments.

About this profile. Compiled from public sources — the organisations' own websites and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights